Cytoplasmic staining of ErbB4 was detected in 89–93% of 53 unselected ovarian cancer tumours using two different anti-ErbB4 antibodies directed to either the cytoplasmic or the extracellular domain of ErbB4 (Gilmour et al, 2001). Here, ERBB4 is linked to ovarian cancer.